Protein A Chromatography Washing Buffer for Impurity Depletion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protein purification methods, particularly for biopharmaceuticals, face challenges in achieving high purity and efficiency due to increased impurity levels such as host cell proteins and molecular variants, which can lead to safety concerns and economic viability issues, especially in large-scale industrial production.
Innovation Solution
A washing buffer for protein A chromatography containing arginine, sodium chloride, isopropanol, polyvinylpyrrolidone, and/or a detergent is used to enhance the purification of proteins by effectively removing impurities, specifically host cell proteins and DNA, with a pH range of 4 to 8, allowing for a single-step process that improves purity and reduces the need for additional purification steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional purification methods are used, then the purification process can be carried out, but the purity of the target protein is insufficient due to high impurity levels
Solution Approach 1:
The patent applies parameter changes by systematically optimizing buffer composition parameters including pH (4.0-8.0), ionic strength (0.1-2.0 M NaCl), and additive concentrations (arginine 0.1-1.0 M, alcohols 5-30%, PVP 0.01-5%, detergents 0.01-1%). These parameter adjustments enable the washing buffer to effectively remove impurities while maintaining target protein binding, directly resolving the purity insufficiency problem
Solution Approach 2:
The patent employs composite materials by formulating a washing buffer containing multiple components working synergistically: arginine (disrupts hydrophobic interactions), sodium chloride (adjusts ionic strength), alcohols (disrupts hydrophobic interactions), PVP (steric hindrance), and detergents (reduce surface tension). This composite approach enhances impurity removal efficiency beyond what single agents could achieve, directly addressing the insufficient purity issue
2Manufacturing precision
If multiple purification steps are used to achieve high purity, then the purity of the target protein increases, but the process complexity and production time increase
Solution Approach 1:
The patent merges multiple purification functions into a single washing step following protein A chromatography. The washing buffer combines impurity removal capabilities (through arginine, alcohols, PVP, and detergents) with protein stabilization functions, enabling what would traditionally require multiple sequential purification steps to be achieved in one operation, thus reducing process complexity while maintaining high purity
Solution Approach 2:
The washing buffer exhibits multi-functionality by simultaneously removing different types of impurities (host cell proteins, DNA, endotoxins, aggregates) while maintaining target protein binding and stability. This universal approach allows a single buffer formulation to perform multiple purification tasks that would otherwise require separate specialized steps, reducing the overall number of purification operations needed
3Productivity
If conventional washing buffers are used, then the purification process can proceed, but additional purification steps are required to achieve sufficient purity
Solution Approach 1:
The patent optimizes buffer parameters including pH (4.0-8.0), ionic strength (0.1-2.0 M NaCl), and additive concentrations (arginine 0.1-1.0 M, alcohols 5-30%, PVP 0.01-5%, detergents 0.01-1%) to enhance impurity removal efficiency in a single washing step, eliminating the need for additional purification operations and thereby improving productivity while maintaining high purity
Solution Approach 2:
The washing buffer enables continuous effective purification action by maintaining target protein binding while simultaneously removing impurities throughout the washing phase. This continuous useful action eliminates gaps where impurities might accumulate and removes the need for interrupting the process with additional purification steps, thereby improving overall purification efficiency and productivity
4Reliability
If extended purification processes are used to ensure safety by removing all impurities, then the safety of biopharmaceuticals improves, but the economic viability decreases
Solution Approach 1:
The patent optimizes buffer parameters (pH 4.0-8.0, NaCl 0.1-2.0 M, arginine 0.1-1.0 M, alcohols 5-30%, PVP 0.01-5%, detergents 0.01-1%) to achieve comprehensive impurity removal in a single efficient washing step, ensuring safety requirements are met without requiring extended multi-step purification processes that would increase manufacturing costs and reduce economic viability
Solution Approach 2:
The washing buffer selectively extracts and removes harmful impurities (host cell proteins, DNA, endotoxins, aggregates) from the target protein preparation in one step. This targeted extraction approach ensures safety by removing all undesirable substances efficiently, eliminating the need for multiple sequential purification steps and thereby maintaining economic viability while meeting safety requirements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described washing buffer significantly increases the purity of target proteins by effectively depleting impurities, reducing host cell proteins and DNA, and streamlining the purification process, thereby enhancing the economic viability and safety of biopharmaceutical production.
Implementation Method 1
a. applying a mobile phase which contains the target protein to a stationary phase which contains protein A, under conditions in which the target protein binds to the stationary phase
Implementation Method 2
b. applying a washing buffer with a pH of between 4 and 8 as mobile phase, containing as additives i. arginine in a concentration of 0.1-1 mol/l, ii. sodium chloride in a concentration of 0.2 to 2 mol/l, iii. an alcohol selected from among isopropanol, n-propanol and ethanol, in a concentration of 5-30% (w/v) and iv. polyvinylpyrrolidone and/or a detergent in a concentration of 0.05-2% (w/v)
Implementation Method 3
c. using an elution buffer as mobile phase under conditions in which the target protein is eluted from the stationary phase
Data Source
AI summary
The present invention relates to methods of depleting impurities, in particular host cell proteins (HCP) and DNA from cell culture supernatants by means of protein A chromatography using a novel washing buffer.